What are the opening hours?

Monday 8am - 5pm Tuesday 8am - 5pm Wednesday 8am - 5pm Thursday 8am - 5pm Friday 8am - 5pm

Aurora Spine

Name: Aurora Spine
Address: 1930 Palomar Point Way, Suite 103, Carlsbad, CA, 92008, US
Telephone: +17604242004
Price range: Not Applicable

Aurora specializes in minimally-invasive, regenerative technologies. Our mission is to be the leader in advanced minimally invasive innovations. Precision.

Aurora Spine™ is dedicated to revolutionizing minimally invasive spine surgery and regenerative medicine to improve patient outcomes. Our cutting-edge implants and technologies are designed to support surgeons and enhance the quality of life for patients, especially those with osteoporosis, osteopenia, and aging spine conditions.

💡 Innovation. Purpose.
📈 Publicly Traded: $ASAPF | $ASG.V
🔗 Learn more: https://www.aurora-spine.com/

09/04/2026

This Labor Day weekend, Aurora Spine recognizes the dedication and hard work of those who help move our industry, our communities, and patient care forward.

We are especially grateful for our team, healthcare professionals, partners, and everyone who shares our commitment to advancing spine care through meaningful innovation.

From all of us at Aurora Spine, we wish you and your loved ones a safe, relaxing, and happy Labor Day weekend. 🇺🇸

$ASAPF | $ASG.V

09/02/2026

Evidence at the center. Integrity in the conversation. 💜

Aurora Spine’s Integrity Campaign highlights the clinical evidence behind zip™ and the context that matters when interpreting it.

A multicenter retrospective review of 32 patients with lumbar degenerative disc disease and lumbar spinal stenosis reported:

• 67% average pain reduction, with mean VAS scores decreasing from 8.1 to 2.65
• No reported adverse events, reoperations, or device removals within 90 days
• Estimated blood loss below 50 mL in every patient

These encouraging findings reflect a small retrospective series without a control group. Longer follow-up and comparative research are needed to assess lasting outcomes.

Explore the evidence. Keep the conversation grounded in facts.

📖 Resource: Falowski et al. *Journal of Pain Research*. 2021;14:1525–1531. Read the study: (https://doi.org/10.2147/JPR.S304957).

$ASAPF $ASG.V

08/31/2026

More than triangular placement. True triangular transfixation.

SiLO TFX™ applies the fundamental principles of arthrodesis through joint preparation, bone graft and three points of stable fixation across the SI joint.

Because successful fusion begins with sound principles.

Contact the Aurora Spine Sales Team to learn more.

08/26/2026

Evidence matters when evaluating options for sacroiliac joint fusion.

The ACCESS Study provides 12 month clinical data on the SiLO TFX™ system from a retrospective, multicenter cohort of 42 patients treated across eight clinical sites.

Key findings at 12 months included:

• Mean pain scores improved from 7.1 to 2.9
• Mean ODI improved from 33.0 to 17.1
• 84.2% of patients achieved a clinically meaningful improvement in pain
• 52.4% achieved at least a 15 point improvement in ODI
• No key serious adverse events or device integrity complications were reported

Both the pain and functional improvements were statistically significant at p < 0.0001.

These results add meaningful clinical evidence to the evolving discussion around posterior SI joint fusion. As a retrospective study with 12 month follow up, the authors also recognize the need for larger prospective studies and longer term evaluation.

Explore the peer reviewed research:
https://doi.org/10.3390/healthcare13131544

Contact the Aurora Spine Sales Team to learn more about SiLO TFX™ and our SI joint solutions.

08/25/2026

L5–S1 is one of the most commonly affected levels in degenerative lumbar spine disease. In the population-based Wakayama Spine Study, MRI-defined intervertebral disc degeneration at L5–S1 was observed in 66.7% of men and 70.9% of women, second in frequency only to L4–L5.¹ Lumbar spinal stenosis is also frequently observed at the lumbosacral level. In a study of 121 patients with clinical symptoms of lateral lumbar spinal stenosis, 43.0% demonstrated grade 2 lateral recess stenosis and 62.0% demonstrated grade 2 foraminal stenosis at L5–S1.² Together, these findings underscore the clinical importance of L5–S1 in degenerative lumbar pathology. The Aurora Spine ZIP™ MIS Interspinous Fusion System provides posterior, non-pedicle supplemental fixation of the non-cervical spine from T1–S1. ZIP is FDA-cleared for supplemental fusion in patients with degenerative disc disease, lumbar spinal stenosis, spondylolisthesis, trauma and/or tumor.³

References
Teraguchi M, et al. Prevalence and distribution of intervertebral disc degeneration over the entire spine in a population-based cohort: The Wakayama Spine Study. Osteoarthritis and Cartilage. 2014;22(1):104–110.
Norisyam Y, et al. Lateral Lumbar Spinal Stenosis: Associations With the Oswestry Disability Index, Visual Analogue Scale, and Magnetic Resonance Imaging. 2023.
Aurora Spine, Inc. ZIP™ MIS Interspinous Fusion System. FDA 510(k) K221399. Cleared July 8, 2022.

08/24/2026

Why does L5–S1 deserve our attention?

Research shows that disc degeneration at L5–S1 affects 66.7% of men and 70.9% of women. At this same level, grade 2 stenosis was identified in 43% of lateral recesses and 62% of neural foramina.

These findings reinforce the clinical importance of L5–S1 and the need for treatment options designed to address degenerative lumbar pathology.

As part of The Integrity Campaign, Aurora Spine is committed to presenting the evidence clearly and allowing the facts to lead the conversation.

The ZIP™ MIS Interspinous Fusion System provides posterior, nonpedicle supplemental fixation from T1–S1 and is FDA cleared for supplemental fusion in patients with degenerative disc disease, lumbar spinal stenosis, spondylolisthesis, trauma, and/or tumor.

Evidence brings clarity. Integrity builds confidence.

Sources:

1. Teraguchi M, et al. *Prevalence and distribution of intervertebral disc degeneration over the entire spine in a population based cohort: The Wakayama Spine Study.* Osteoarthritis and Cartilage. 2014;22(1):104–110.
https://pubmed.ncbi.nlm.nih.gov/24239943/

2. Norisyam Y, et al. *Lateral Lumbar Spinal Stenosis: Associations With the Oswestry Disability Index, Visual Analogue Scale, and Magnetic Resonance Imaging.* Cureus. 2023.
https://pubmed.ncbi.nlm.nih.gov/38226127/

3. Aurora Spine, Inc. ZIP™ MIS Interspinous Fusion System. FDA 510(k) K221399. Cleared July 8, 2022.
https://www.accessdata.fda.gov/cdrh_docs/pdf22/K221399.pdf

08/20/2026

The proprietary ZIP One-Step™ locking mechanism eliminates the need for a set screw, simplifying the procedure with a single, secure motion.

A minimally invasive posterior lumbar interspinous fixation implant, designed for strength, efficiency, and stability.

08/19/2026

Stabilizing the spine, relieving pain. The zip™ 51 implant from Aurora Spine offers a minimally invasive solution.

08/16/2026

Instagram got a fresh new look… so we’re having a little fun with it this Sunday. 😎

Consider this our weekend tribute to the new wordmark, Aurora Spine style.

Same name. Same mission. Just having a little Sunday fun with the font. 💜

What do you think… should we keep it? 👀

08/10/2026

L5–S1 is one of the most commonly affected levels in degenerative lumbar spine disease. In the population-based Wakayama Spine Study, MRI-defined intervertebral disc degeneration at L5–S1 was observed in 66.7% of men and 70.9% of women, second in frequency only to L4–L5.¹

Lumbar spinal stenosis is also frequently observed at the lumbosacral level. In a study of 121 patients with clinical symptoms of lateral lumbar spinal stenosis, 43.0% demonstrated grade 2 lateral recess stenosis and 62.0% demonstrated grade 2 foraminal stenosis at L5–S1.²

Together, these findings underscore the clinical importance of L5–S1 in degenerative lumbar pathology. The Aurora Spine ZIP™ MIS Interspinous Fusion System provides posterior, non-pedicle supplemental fixation of the non-cervical spine from T1–S1. ZIP is FDA-cleared for supplemental fusion in patients with degenerative disc disease, lumbar spinal stenosis, spondylolisthesis, trauma and/or tumor.³

References
1.Teraguchi M, et al. Prevalence and distribution of intervertebral disc degeneration over the entire spine in a population-based cohort: The Wakayama Spine Study. Osteoarthritis and Cartilage. 2014;22(1):104–110.
2.Norisyam Y, et al. Lateral Lumbar Spinal Stenosis: Associations With the Oswestry Disability Index, Visual Analogue Scale, and Magnetic Resonance Imaging. 2023.
3.Aurora Spine, Inc. ZIP™ MIS Interspinous Fusion System. FDA 510(k) K221399. Cleared July 8, 2022.

Address

1930 Palomar Point Way, Suite 103
Carlsbad, CA
92008

Opening Hours

Monday	8am - 5pm
Tuesday	8am - 5pm
Wednesday	8am - 5pm
Thursday	8am - 5pm
Friday	8am - 5pm

Telephone

+17604242004

Website

https://www.aurora-spine.com/

Alerts

Be the first to know and let us send you an email when Aurora Spine posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Aurora Spine:

Want your business to be the top-listed Equipment Service in Carlsbad?